Download Biomedical Technologies Horizon Scanning & Procurement

Technology in Care
Andrew Marsden
Medical Advisor, National Procurement
Technology in Care
National
Procurement
Biomedical Technologies
Horizon Scanning & Procurement
Pure
Science
Applied
Science
Product
Development
Safety, Efficacy /
Value Guidance
Health
Service
Provider
Medical
&Surgical
Practice
Patient
Unmet
Need
National
Procurement
Targeted / Wider Indications
Breakthroughs
Increase Leads & Targets
Biology
Medicine / Biomedical Research
Pharmaceuticals
Molecular Engineering
IV Diagnostics
Bioengineering
Imaging –Molecular Diagnistic Contrast, Dual Subtraction
- Genetics /Proteomics
Chemistry – Molecular /
Combinatorial Chemistry
Physics – Biomaterials / Nano-Technologies
Mathematics & Computational
Biomechanical / Mechanical Engineering
Procedures – MIS , Screening
Bioinformatics
Biomedical Devices – Convergence
IT / Computational Engineering
Expectation
- Lab on a Chip
Bio photonics
Electronic,/ Electrical Engineering
Higher
– Large Molecule / MABS / RNAi
IT & Communications – WIRELESS, DICOM & EPR
Software Engineering
Etc etc + Convergence & Complexity
Pure
Science
Applied
Science
Product
Development
Safety, Efficacy /
Value Guidance
Health
Service
Provider
Medical
&Surgical
Practice
Patient
Unmet
Need
Wave of Innovation…
National
Procurement
Targeted / Wider Indications
Breakthroughs
Increase Leads & Targets
Biology
Medicine / Biomedical Research
Pharmaceuticals
Molecular Engineering
IV Diagnostics
Bioengineering
Imaging –Molecular Diagnostic Contrast, Dual Subtraction
- Genetics /Proteomics
Chemistry – Molecular /
Combinatorial Chemistry
Physics – Biomaterials / Nano-Technologies
Mathematics & Computational
Biomechanical / Mechanical Engineering
Procedures – MIS , Screening
Bioinformatics
Biomedical Devices – Convergence
IT / Computational Engineering
Expectation
- Lab on a Chip
Bio photonics
Electronic,/ Electrical Engineering
Higher
– Large Molecule / MABS / RNAi
IT & Communications – WIRELESS, DICOM & EPR
Software Engineering
Etc etc + Convergence & Complexity
TRANSLATIONAL RESEARCH
Pure
Science
Applied
Science
Product
Development
Safety, Efficacy /
Value Guidance
Health
Service
Provider
Medical
&Surgical
Practice
COLLABORATION / INNOVATION
ANTICIPATE
Horizon Scanning Centre
APPRAISING/
REGULATING
Health Technology
Assessment (HTA)
NICE (1999) / SMC (2002)
COLLABORATE
•Trial/ In-Line Evidence Development
•Clinical Outcome Registries
•Risk Sharing Deals
•Strategic / Aligned procurement
Patient
Unmet
Need
National
Procurement
The Scottish Health Technologies
Group
SGHD Patients and Quality
Division
•
Board Medical Directors
•
Directors Public Health
•
NHSQIS
•
Regional Planning Group
•
Board Chief Executives
•
•
Medicines Management
Consultant
Board Finance Directors
•
Lay Representative
•
National
Procurement
Remit of SHTG
•
•
•
To identify existing and new technologies, including devices, which
are likely to have significant implications for patient care in the NHS
in Scotland, and areas where there may be evidence to support
disinvestment
To ensure that assessment and appraisal of the effectiveness of
technologies is carried out as needed, taking account of
assessment and appraisal work being carried out elsewhere, for
example, by NICE, by the Centre for Evidence-based Purchasing,
and by other Technology Assessment groups
To facilitate the implementation by the NHS in Scotland of
evidence-based recommendations on technologies including NHS
QIS Health Technology Assessments and NICE Technology
Appraisals
The group is advisory and has no directorial control over Health
Boards
National
Procurement
Business of SHTG
Scottish Health Technologies Group (SHTG)
•Horizon Scanning
•Appraisal of key topics, to include disinvestment of older technologies
•Supporting Implementation of Recommendations that are a material change to current practice
• Monitoring the take up of such initiatives
Quality Improvement Scotland (QIS) will…
•Prepare and circulate a quarterly horizon scanning report
•Maintain a register of all topics
•Record all decisions and actions
•Prepare and circulate systematic reviews and evidence notes of the clinical and cost
effectiveness evidence for topics requested
•Prepare and issue to NHS Scotland implementation advice as requested
National
Procurement
Sources of Horizon Scanning
i.
Non drug Technology Briefings issued by the National Horizon Scanning Centre University of
Birmingham
ii.
New HTAs that have entered the NHS QIS work programme since last horizon scanning
Report
iii.
Non drug HTAs published by i) NHS QIS ii) the National Coordinating Centre for Health
Technology Assessment (includes all undertaken for NICE) and iii) those published by other
international agencies
iv.
SIGN Guidelines that have been consulted on since last horizon scanning report
v.
NICE: Interventional Procedures
vi.
Evidence Notes
vii.
Topic proposals by Group members
viii. Topic proposals by National Procurement on new technologies and divestment
National
Procurement
Role of Procurement ?
Strategic Procurement
Tactical Procurement
Define
Requirement
Company Pipelines
Targeted / Informed
Priorities
Customer Alignment
Horizon
Scanning
Research
Supply
Market
Tender /
Product
Scoring
Publish Quantitive
Market Data /
Commercial
Research
Strategic
Collaboration
Supplier
Selection
Contract /
Implement
Market Status Update /
Product Scoring &
Ranking
Health Technology
Assessment
P2P
(Purchase
to Pay
Manage Supplier /
Monitor Uptake
Market Tracking
Actual vs committed
Monitor Uptake/
Assess Impact
National
Procurement
Procurement Scanning opportunity?
CARDIOLOGY ( VASCULAR)
Current
Medical devices &
Instruments
MUSCULOSKELETAL
GASTROENTEROLOGY
LABS / IV DIAGNOSTICS
CARDIOVASCULAR
ANEASTHETICS
RENAL
RADIOLOGY
DENTAL
OPTHALMOLOGY
AUDIOLOGY
GYNEACOLOGY
NEUROLOGY
REHAB & SUPPORTIVE
SURGICAL
TOTAL
36,975,000
16,650,000
15,700,000
7,900,000
7,890,000
7,750,000
6,417,631
5,700,000
4,500,000
4,305,000
500,000
?
37,465,000
7,650,000
162,322,807
•Drug Eluting Stents
•Bare Metal Stents
•Catheters & Ballons
•Hydrophilic / Hydrophobic Guidaewires
•IVUS Imaging
Emerging
•Bioactive stents
•Bifurcation Stents
•PFO Closure Device
•Carotid Artery/ Full Body Stenting
Future
•Bioresorbable Stents
•Vulnerable Plaque
•MS CT Angiography
•C Reactive Protein Screening
• Incremental vs. Disruptive ?
• Changes / Additions to Indications ?
• Rate of Change & momentum ?
• Financial Impact / Commercial Context ?
National
Procurement
Areas of NP Involvement
•Input from commodity leads on market research in their areas of special interest
•Information from major suppliers and trade organisations on technology road-mapping
•Proposals for specific Health Technology Assessments on emerging areas
•Contribution on the take-up of new technologies (and the disinvestment of old) through
the monitoring of the implementation of new national contracts
•Information on clinical outcomes following the introduction of a new technology
•Events & Reporting
National
Procurement
"The NP Horizon Scan Report"




Brief Description of the Technology
Likely Patient Group/s
Current Treatment Alternatives
Level and amount of research evidence currently
available (if known)
 Prediction of clinical and strategic relevance
National
Procurement
"The NP Implementation Report"
 Identify the value added of a strategically
sourced contract OR manage the supplier-tocustomer processes
 Provide information to inform business cases
and track implementation activity
 to monitor take up rates for new technology
OR
 displacement rates for disinvested products
National
Procurement
Outputs from NHSQIS
• Evidence-based
Assessment Report
• Supervision of
Work Programme
• Publication on
website
Report of evidence based assessments
from Scottish Health Technologies Group
April 2008
HTA Programme: Report no HSRE/2008/001A
Health Services Research and Effectiveness Unit
National
Procurement
Current Examples
• Blood Glucose Monitoring
• Insulin Pumps
• CPAP for Obstructive Sleep Apnoea
• Flexible Endoscopy technologies including nasal intubation and
double balloon colonoscopy
• Interventional cardiology technologies including coronary stents and
percutaneous valve insertion
•Blood Scavenging
•Digital mammography in breast screening
• Dual Energy Subtraction Radiology
• Tissue Viability Products e.g. Topical Negative Pressure; active microstimulation mattresses
• Haemostatic Agents